Health
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent company earlier this year, via a stock exchange offer. J&J […]
Read More
Warning labels in the U.S. seem to be everywhere. Here’s why they may be pointless
Warning labels are designed to inform consumers about potential risks of using a product, but they have become too prevalent to be beneficial. “Warning labels really were fairly rare until the 1960s,” said W. Kip Viscusi, a distinguished professor of law, economics, and management at Vanderbilt University. “Beginning in the mid-1960’s, cigarettes started to have […]
Read More
Pfizer says no major tornado damage to drug manufacturing areas of North Carolina facility
In this aerial image, damage is seen to a Pfizer pharmaceutical factory after a tornado hit the facility two days earlier, on July 21, 2023 in Rocky Mount, North Carolina. Sean Rayford | Getty Images Pfizer on Friday said there does not appear to be major damage to the drug manufacturing areas of its plant […]
Read More
Here’s what Jim Cramer thinks about J&J stock after a pivotal talc case verdict
A closely watched talc trial in California goes against Johnson & Johnson (JNJ), adding uncertainty around whether tens of thousands of other plaintiffs suing the company will sign on to J & J’s proposed $8.9 billion settlement offer or seek to get their own days in court. Jim Cramer believes the biopharmaceutical company was “too […]
Read More
Ford’s dividend quality, J&J’s split-off, cost basis discipline — what we think about all these
Send your questions directly to Jim Cramer and his team of analysts at [email protected] . Reminder, we can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. Question 1: What are your thoughts on the stability of FORD’s dividend? Thank you, Denise The quickest […]
Read More
Biden administration calls on employers to help keep people insured as millions lose Medicaid
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images The Biden administration on Thursday called on companies to help keep their employees insured as millions […]
Read More
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here’s what you need to know
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson on Thursday said its shareholders will soon be able to swap […]
Read More
J&J’s strong quarter was amplified by new details around its big Kenvue consumer unit stake
Johnson & Johnson (JNJ) reported strong second – quarter profit and revenue before the opening bell Thursday, with better-than-expected results both domestically and internationally, as well as across all major operating segments. J & J’s second-quarter reported sales rose 6.3% year-over-year to $25.53 billion, exceeding the Refinitv consensus estimate of $24.63 billion. (On an adjusted […]
Read More
Kenvue earnings top estimates in J&J spinoff’s first quarterly report since IPO
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company’s first quarterly report since it spun out from Johnson & Johnson two months ago. The company also issued an upbeat sales outlook […]
Read More
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped. The medtech division provides devices for surgeries, orthopedics and vision. The company is benefitting from a rebound in demand for non-urgent surgeries among older adults, who […]
Read More